Ligand Pharmaceuticals Incorporated (LGND) Free Cash Flow
Ligand Pharmaceuticals Incorporated (LGND) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $61.88M |
| 2017-12-31 | $93.47M |
| 2018-12-31 | $193.17M |
| 2019-12-31 | $780.91M |
| 2020-12-31 | $50.13M |
| 2021-12-31 | $70.04M |
| 2022-12-31 | $119.93M |
| 2023-12-31 | $46.06M |
| 2024-12-31 | $95.23M |
| 2025-12-31 | $48.91M |
How LGND compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| BRKR | Bruker Corporation | $43.30M |
| PAHC | Phibro Animal Health Corporation | $41.83M |
| NEOG | Neogen Corporation | $31.90M |
| ADMA | ADMA Biologics Inc | $27.50M |
| INNV | InnovAge Holding Corp. | $26.60M |
These are five companies in the same sector as LGND with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("LGND", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LGND | $280.49 | -1.42% | 0.13M |
| 3 | ||||
| 4 | ||||
| 5 |